The landscape of dementia analysis has developed substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of indicators emerge. While these technological innovations characterize impressive progress in being familiar with neurodegenerative disorders, the... https://devendran542qal3.tusblogos.com/profile